Clinical Trials in Houston

Showing 3081-3100 of 8,625 trials

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

NCT04822298

This study aims to evaluate the safety and tolerability of AMG 160 and to evaluate the maximum tolerated dose (MTD) or the recommended phase 2 dose (RP2D).

Non-small Cell Lung CancerNSCLC

Amgen3 participantsStarted Aug 2021

Houston, Texas, United States • Camperdown, New South Wales, Australia • Salzburg, Austria +1 more locations

COMPLETEDPhase 2< 1 mile

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

NCT05349643

AMB-051-07 is an open-label, adaptive, dose-ranging study with long-term extension in adults with tenosynovial giant cell tumor

Pigmented Villonodular SynovitisTGCTTenosynovial Giant Cell Tumor

AmMax Bio, Inc.20 participantsStarted Jan 2023

Sacramento, California, United States • Miami, Florida, United States • Houston, Texas, United States +3 more locations

COMPLETEDPhase 1< 1 mile

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

NCT00254384

This phase I trial studies docetaxel, cisplatin, and erlotinib hydrochloride in treating patients with stage I-III non-small cell lung cancer following surgery. Drugs used in chemotherapy, such as docetaxel and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving docetaxel, cisplatin, and erlotinib hydrochloride together may kill more tumor cells.

Recurrent Lung Non-Small Cell CarcinomaStage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7+4 more

M.D. Anderson Cancer Center50 participantsStarted Oct 2005

Houston, Texas, United States

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

Find Trials by Condition in Houston

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

LSTR in Chevron Osteotomy

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

TRC-PAD Program: In-Clinic Trial-Ready Cohort

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma